Skip to main content
SpringerLink
Log in

Pharmacologic Management of Allergic Disease and Sleep

  • Chapter
  • First Online:
Allergy and Sleep

Abstract

Sleep disturbance affects up to 60% of children suffering from allergic diseases and is the leading cause of reduced quality of life in this population. Lack of sleep can have detrimental consequences on a child’s neurocognitive development and growth. The etiology of the disease is multifactorial with proposed inflammation mechanisms mediated by T lymphocytes, cytokines, reduced melatonin, and increased IgE. Due to circadian fluctuations of inflammatory mediators, patients often experience worsening symptoms during the night. The following chapter will review the role of antihistamines (oral and nasal), melatonin, clonidine, chloral hydrate, doxepin, montelukast, benzodiazepines, hypnotics (zaleplon, zolpidem, and eszopiclone), topical therapies, steroids (topical, inhaled, and intranasal), and immunomodulatory therapies (calcineurin inhibitors, antimetabolites, steroids, and dupilumab) in improving sleep for various allergic diseases. In addition to the efficacy and safety of these agents, pregnancy and lactation considerations will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Koinis-Mitchell D, Craig T, et al. Sleep and allergic disease: a summary of literature and future directions for research. J Allergy Clin Immunol. 2012;130(6):1275–81.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chang YS, Chiang BL. Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin. Int J Mol Sci. 2016a;17(4):462.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Fishbein AB, Mueler K, Lacey K, et al. Sleep disturbance in children with moderate/severe atopic dermatitis: a case-control study. J Am Acad Dermatol. 2017;78:336. https://doi.org/10.1016/j.jaad.2017.08.043. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  4. Chang YS, Lin MH, Lee JH, et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr. 2016a;170(1):35–42.

    Article  PubMed  Google Scholar 

  5. Kelsay K. Management of sleep disturbance with atopic dermatitis. J Allergy Clin Immunol. 2006a;118(1):198–201.

    Article  PubMed  Google Scholar 

  6. Koinis-Mitchell D, Kopel SJ, Boergers J, et al. Asthma, allergic rhinitis, and sleep problems in urban children. J Clin Sleep Med. 2015;11(2):101–10.

    PubMed  PubMed Central  Google Scholar 

  7. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Yanai K, Ryu JH, Watanabe T, et al. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br J Pharmacol. 1995;116(1):1649–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pelayo R, Chen W, Monzon S, et al. Pediatric sleep pharmacology: you want to give my kid sleeping pills? Pediatr Clin N Am. 2004;51:117–34.

    Article  Google Scholar 

  10. Simons FE. H1-antihistamines in children. Clin Allergy Immunol. 2002;17:43–64.

    Google Scholar 

  11. Russo RM, Guruaj VJ, Allen JE. The effectiveness of diphenhydramine HCl in pediatric sleep disorders. J Clin Pharmacol. 1976;16(5–6):284–8.

    Article  CAS  PubMed  Google Scholar 

  12. Gengo F, Gabos C, Miller JK. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther. 1989;45(1):15–21.

    Article  CAS  PubMed  Google Scholar 

  13. Merenstein D, Diener-West M, Halbower AC, Krist A, Rubin HR. The trial of infant response to diphenhydramine: the TIRED study--a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006;160(7):707–12.

    Article  PubMed  Google Scholar 

  14. Munday J, Bloomfield R, Goldman M, et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology. 2002;205:40–5.

    Article  CAS  PubMed  Google Scholar 

  15. Simons FE, Simons KJ, Becker AB, et al. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. J Pediatr. 1984;104(1):123–7.

    Article  CAS  PubMed  Google Scholar 

  16. Klein GL, Galant SP. A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. Ann Allergy. 1980;44(3):142–5.

    CAS  PubMed  Google Scholar 

  17. Novak N and Leung DYM (2016) Role of barrier dysfunction and immune response in atopic dermatitis. In Leung DYM, Szefler SJ, Bonilla F A, Cezmi AA, Hugh H (3rd ed.) Pediatric allergy: principles and practice. Elsevier, Toronto, pp 438–447.

    Chapter  Google Scholar 

  18. Boguniewicz M, Leung DYM. Management of atopic dermatitis. In: DYM L, Szefler SJ, Bonilla FA, Cezmi AA, Hugh H, editors. Pediatric allergy: principles and practice. 3rd ed. Toronto: Elsevier; 2016. p. 448–57.

    Chapter  Google Scholar 

  19. Hu Y, Sieck DE, Hsu WH. Why are second-generation H1-antihistamines minimally sedating? Eur J Pharmacol. 2015;765:100–6.

    Article  CAS  PubMed  Google Scholar 

  20. La Rosa M, Ranno C, Musarra I, et al. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy. 1994;73(2):117–22.

    PubMed  Google Scholar 

  21. Klein PA, Clark RAF. An evidence-based review of efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135(12):1522–55.

    Article  CAS  PubMed  Google Scholar 

  22. Ng KH, Chong D, Wong CK, et al. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics. 2004;113(2):e116–21.

    Article  PubMed  Google Scholar 

  23. Diepgen TL. Early treatment of the atopic child study group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol. 2002;13:278–86.

    Article  PubMed  Google Scholar 

  24. Del Cuvillo A, Sastre J, Montoro J, et al. Use of antihistamines in pediatrics. J Investiga Allergol Clin Immunol. 2007;17(Suppl 2):28–40.

    Google Scholar 

  25. Use caution when giving cough and cold products to kids. (2016, November 4). Retrieved from https://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm263948.htm.

  26. National Institute for Health & Care Excellence (NICE): Clinical Guidelines. Atopic Res. 2007;39(6):559–65.

    Google Scholar 

  27. Seidman MD, Gurel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1 Suppl):S1–43.

    Article  PubMed  Google Scholar 

  28. Chang YS, Chou YT, Lee JH, et al. Atopic dermatitis, melatonin, and sleep disturbance. Pediatrics. 2014;134(2):e397–405.

    Article  PubMed  Google Scholar 

  29. Masters A, Pandi-Parumal SR, Seixas A, et al. Melatonin, the hormone of darkness: from sleep promotion to Ebola treatment. Brain Disord Ther. 2014;4(1).

    Google Scholar 

  30. Xie Z, Chen F, Li WA, et al. A review of sleep disorders and melatonin. Neuro Res. 2017;39(6):559–65.

    Article  CAS  Google Scholar 

  31. Carrillo-Vico A, Lardone PJ, Alvarez-Sanchez N, et al. Melatonin: buffering the immune system. Int J Mol Sci. 2013;14(4):8638–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Cikler E, Ercan F, Cetinel S, Contuk G, Sener G. The protective effects of melatonin against water avoidance stress-induced mast cell degranulation in dermis. Acta Histochem. 2005;106(6):467–75.

    Article  CAS  PubMed  Google Scholar 

  33. Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr. 2016b;170(1):35–42.

    Article  PubMed  Google Scholar 

  34. Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–81.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 2005;20(12):1151–8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Brown KM, Malow BA. Pediatric Insomnia. Chest. 2016;149(5):1332–9.

    Article  PubMed  Google Scholar 

  37. Genois A, Haig M, Des Roches A, et al. Case report of atopic dermatitis with refractory pruritus markedly improved with the novel use of clonidine and trimeprazine. Pediatr Dermatol. 2014;31(1):76–9.

    Article  PubMed  Google Scholar 

  38. Kelsay K. Management of sleep disturbance associated with atopic dermatitis. J Allergy Clin Immunol. 2006b;118(1):198–201.

    Article  PubMed  Google Scholar 

  39. Miyazaki S, Uchida S, Mukai J, Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci. 2004a;58(2):138–44.

    Article  CAS  PubMed  Google Scholar 

  40. Danchin N, Genton P, Atlas P, Anconina J, Leclere J, Cherrier F. Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int J Clin Pharmacol Ther. 1995;33(1):52–5.

    CAS  PubMed  Google Scholar 

  41. Nguyen MTS, Rahmani M, Shapiro M. A review of the use of clonidine as a sleep aid in child and adolescent population. Clin Pediatr. 2014a;53(3):211–6.

    Article  Google Scholar 

  42. Nguyen M, Tharani S, Rahmani M, et al. A review of the use of clonidine as a sleep aid in child and adolescent population. Clin Pediatr. 2014b;53(3):211–6.

    Article  Google Scholar 

  43. Miyazaki S, Uchida S, Mukai J, et al. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci. 2004b;58(2):38–44.

    Article  Google Scholar 

  44. Gotoh Y, Andoh T, Kuraishi Y. Clonidine inhibits itch-related response through stimulation of alpha(2)-adrenoceptors in the spinal cord in mice. Eur J Pharmacol. 2011;650:215–9.

    Google Scholar 

  45. Gotoh Y, Omori Y, Andoh T, et al. Tonic inhibition of allergic itch signaling by the descending noradrenergic system in mice. J Pharmacol Sci. 2011;115(3):417–20.

    Article  CAS  PubMed  Google Scholar 

  46. Elkersh MA, Simopoulous TT, Malik AB, et al. Epidural clonidine relieves intractable neuropathic itch associated with herpes zoster-related pain. Reg Anesth Pain Med. 2003;28(4):344–6.

    CAS  PubMed  Google Scholar 

  47. Horacek HJ. Extended-release clonidine for sleep disorders. J Am Acad Child Adolesc Psychiatry. 1994;33(8):1210.

    Article  CAS  PubMed  Google Scholar 

  48. Owens JA. Pharmacotherapy of pediatric insomnia. J Am Acad Child Adolesc Psychiatry. 2009;48(2):99–107.

    Article  PubMed  Google Scholar 

  49. Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011;32(3):939–62.

    Article  PubMed  Google Scholar 

  50. Nordt SP, Rangan C, Hardmaslani M, et al. Pediatric chloral hydrate poisonings and death following outpatient procedural sedation. J Med Toxicol. 2014;10(2):219–22.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Practices IFSM. Chloral hydrate: is it still being used? Are there safer alternatives? Nurse Advice ERR. 2016;14:1–6.

    Google Scholar 

  52. Hill GD, Walbergh DB, Frommelt PC. Efficacy of reconstituted oral chloral hydrate from crystals for echocardiography sedation. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr. 2016;29(4):337–40.

    Article  Google Scholar 

  53. Adhya Z, Karim Y. Doxepin may be a useful pharmacotherapeutic agent in chronic urticaria. Clin Exp Allergy. 2015;45:1370.

    Article  CAS  PubMed  Google Scholar 

  54. Figueiredo A, Ribeiro C, Goncalo M, et al. Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol. 1990;4(2):147–58.

    Article  CAS  Google Scholar 

  55. Vande Griend JP, Anderson SL. Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc. 2012;52:e210–9.

    Article  Google Scholar 

  56. Yeung WF, Chung KF, Yung KP, et al. Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev. 2015;19:75–83.

    Article  PubMed  Google Scholar 

  57. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines \ for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007:S94–138.

    Google Scholar 

  58. Wilson AM, P’byrne PM, parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004;116(5):338–44.

    Article  CAS  PubMed  Google Scholar 

  59. Barr JG. Allergic rhinitis in children. BMJ. 2014; 349:g4153. https://doi.org/10.1136/bmj.g4153. Immunology, S94–138.

    Article  PubMed  CAS  Google Scholar 

  60. Jeon Y, Min T, Yang HJ, et al. A double-blind, randomized, crossover study to compare the effectiveness of montelukast on atopic dermatitis in Korean children. Allergy Asthma Immunol Res. 2016;8:305–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Lee AY. Is montelukast beneficial in children with atopic dermatitis? Allergy Asthma Immunol Res. 2016;8:279–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ehlayel M, Bener A, Sabbah A. Montelukast treatment in children with moderately severe atopic dermatitis. Eur Ann Allergy Clin Immunol. 2007;39:232–6.

    Google Scholar 

  63. DiPiro JT, Talbert RL, et al. Pharmacotherapy: a pathophysiological approach. New York: McGraw-Hill Medical; 2005.

    Google Scholar 

  64. Buysee DJ. Insomnia. JAMA. 2013;309(7):706–16.

    Article  Google Scholar 

  65. Winkelman JW. Insomnia Disorder. N Engl J Med. 2015;373:1437–44.

    Article  CAS  PubMed  Google Scholar 

  66. Nowell PD. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278(24):2170–7. https://doi.org/10.1001/jama.278.24.2170.

    Article  CAS  PubMed  Google Scholar 

  67. Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162(2):225–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Becker PM, Somiah M. Non–benzodiazepine receptor agonists for insomnia. Sleep Med Clin. 2015;10(1):57–76. https://doi.org/10.1016/j.jsmc.2014.11.002.

    Article  PubMed  Google Scholar 

  69. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335–50. https://doi.org/10.1007/s11606-007-0251-z.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Stranks EK, Crowe SF. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. J Clin Exp Neuropsychol. 2014;36(7):691–700. https://doi.org/10.1080/13803395.2014.928268.

    Article  PubMed  Google Scholar 

  71. Carbone A, Siu A, Patel R. Pediatric atopic dermatitis: a review of the medical management. Ann Pharmacother. 2010;44:1448–58.

    Article  PubMed  Google Scholar 

  72. Sugarman J, Parrish L. Efficacy of a lipid-based barrier repair formulation in moderate to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009;8:1106–11.

    Google Scholar 

  73. Eichenfeld LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71:116–32.

    Article  Google Scholar 

  74. Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26:633–40.

    Article  CAS  PubMed  Google Scholar 

  75. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized control trials. BMJ. 1998;317(7173):1624–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Van Maanen A, Wijga AH, Gehring U, et al. Sleep in children with asthma: results of the PIAMA study. Eur Respir J. 2013;41(4):832–7. https://doi.org/10.1183/09031936.00019412.

    Article  PubMed  Google Scholar 

  77. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med. 2012;367(10):904–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Jasiak NM, Park JM. Immunosuppression in solid-organ transplantation: essentials and practical tips. Crit Care Nurse Q. 2016;39(3):227–40.

    Article  Google Scholar 

  79. Slater NA, Morrell DS. Systemic therapy of childhood atopic dermatitis. Clin Dermatol. 2015;33:289.

    Article  PubMed  Google Scholar 

  80. Thomson J, Wernham A, Williams H. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY ADCHRONOS): a critical appraisal. Br J Dermatol. 2018;178:897.

    Article  CAS  PubMed  Google Scholar 

  81. Pregnancy categories for prescription drugs. FDA Drug Bull. 1982;12:24–5.

    Google Scholar 

  82. American Academy of Pediatrics Committee on Drugs: transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776–89.

    Google Scholar 

  83. Okun ML, Ebert R, Saini B. A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol. 2015;212(4):428–41. https://doi.org/10.1016/j.ajog.2014.10.1106.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

    Natalia M. Jasiak-Panek, Kevin T. Le, Thomas Moran & Sukhraj Mudahar

Authors
  1. Natalia M. Jasiak-Panek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin T. Le
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Moran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sukhraj Mudahar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Natalia M. Jasiak-Panek .

Editor information

Editors and Affiliations

  1. Northwestern University, Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

    Anna Fishbein

  2. Northwestern University, Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

    Stephen H. Sheldon

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jasiak-Panek, N.M., Le, K.T., Moran, T., Mudahar, S. (2019). Pharmacologic Management of Allergic Disease and Sleep. In: Fishbein, A., Sheldon, S. (eds) Allergy and Sleep. Springer, Cham. https://doi.org/10.1007/978-3-030-14738-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-14738-9_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-14737-2

  • Online ISBN: 978-3-030-14738-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation